Eighteen months into the COVID-19 pandemic, the Vivli team, led by Executive Director, Rebecca Li, were among the authors of a paper that analyzed data sharing intentions among trials registered through clinicaltrials.gov. The team found that positive intentionality to share IPD remained static at 15% in this much larger sample size of 2,759 relevant trials (COVID interventional trials).

However, a comparison of declared intention to share IPD in data sharing statements at the time of publication revealed a noticeable shift: affirmative intentions grew from 21.4% to 57%. Within the subset of studies published within journals affiliated with the International Committee of Medical Journal Editors (ICMJE), positive sharing intentions were even higher as indicated in data sharing statements (65%).